Cancer Research UK logo.
SearchDonate
  • Search

A trial of acupuncture for nerve damage symptoms that chemotherapy can cause (ACUFOCIN)

Overview

Cancer types:

Anal cancer, Bile duct cancer, Biliary tree cancers, Bowel (colorectal) cancer, Breast cancer, Gallbladder cancer, Myeloma, Oesophageal cancer, Ovarian cancer, Pancreatic cancer, Stomach cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at acupuncture and usual treatment for a type of nerve damage. This nerve damage is called peripheral neuropathy and chemotherapy can cause it.

One of the side effects of chemotherapy can be peripheral neuropathy. This can cause nerve pain and loss of feeling. It may also affect balance. It most often affects the feet and hands. But it might also cause problems with nerves elsewhere in the body.

This trial was for people who had 1 of the following types of cancer:

  • a type of blood cancer called myeloma

  • breast cancer

  • such as stomach cancer

  • ovarian cancer

The trial was open for people to join between 2015 and 2018. The team presented the results at a conference in 2020.

Recruitment start: 19 March 2015

Recruitment end: 8 October 2018

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Prof Andrew Wardley

Supported by

Manchester Clinical Trials Unit (MCTU)

National Institute for Health Research (NIHR)

NIHR Clinical Research Network: Cancer

The Christie NHS Foundation Trust

Last reviewed: 13 Jan 2022

CRUK internal database number: 12878

Help and support